跳至主要内容
临床试验/ACTRN12623000281695
ACTRN12623000281695尚未招募未知

Injectable cabotegravir and rilpivirine Observational Study in Australian tertiary and primary care settings. of HIV positive adults and primary care workers A Cohort Study. (ICAROS)

Prahran Market Clinic0 个研究点目标入组 300 人开始时间: 2023年3月15日最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • The Principal Investigator has approached GP practises & Hospitals who care for patients living with HIV for their interest in participating & several sites have expressed interest. Participants & Health Care workers who are commencing or recently commenced Cabenuva will be eligible.

排除标准

  • HIV positive patients not on Cabenuva & Health Care workers not administrating or prescribing Cabenuva

研究者

发起方
Prahran Market Clinic

相似试验